title: MicroRNA-146a suppresses metastatic activity in brain metastasis.
abstract: Primary lung tumors, breast tumors, and melanoma metastasize mainly in the brain where therapy is limited to surgery and radiation. To investigate the molecular basis of brain metastases, we isolated brain-trophic metastatic MDA-MB-435-LvBr2 (LvBr2) cells via left ventricle (LV) injection of MDA-MB-435 cells into immunodeficiency (NOD/SCID) mice. Whereas parent MDA-MB-435 cells displayed an elongated morphology, LvBr2 cells were round and displayed an aggregated distribution. LvBr2 cells expressed lower β-catenin levels and higher heterogeneous nuclear ribonucleoprotein C1/C2 (hnRNPC) levels than parental cells. Since microRNAs are known to play an important role in cancer progression including metastasis, we screened microRNAs expressed specifically in brain metastases. MicroRNA-146a was almost undetectable in LvBr2 cells and highly expressed in the parental cells. Overexpression of miR-146a increased β-catenin expression and suppressed the migratory and invasive activity of LvBr2 cells. The miR-146a-elicited decrease in hnRNPC in turn lowered the expression of MMP-1, uPA, and uPAR and inhibited the migratory and invasive activity of LvBr2 cells. Taken together, our findings indicate that miR-146a is virtually absent from brain metastases and can suppress their metastatic potential including their migratory and invasive activities associated with upregulation of β-catenin and downregulation of hnRNPC.
authors.affiliation: Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, 135-710, Korea.
authors.forename: Su Jin
authors.initials: SJ
authors.lastname: Hwang
authors.forename: Ho Jun
authors.initials: HJ
authors.lastname: Seol
authors.forename: Young Mi
authors.initials: YM
authors.lastname: Park
authors.forename: Kang Ho
authors.initials: KH
authors.lastname: Kim
authors.forename: Myriam
authors.initials: M
authors.lastname: Gorospe
authors.forename: Do-Hyun
authors.initials: DH
authors.lastname: Nam
authors.forename: Hyeon Ho
authors.initials: HH
authors.lastname: Kim
mesh_terms: D000818:Animals; D001932:Brain Neoplasms / Q000235:genetics* / Q000473:pathology / Q000556:secondary*; D045744:Cell Line, Tumor; D015972:Gene Expression Regulation, Neoplastic; D034482:Heterogeneous-Nuclear Ribonucleoprotein Group C / Q000235:genetics; D020781:Matrix Metalloproteinase 1 / Q000235:genetics; D051379:Mice; D035683:MicroRNAs / Q000235:genetics*; D014568:Urokinase-Type Plasminogen Activator / Q000235:genetics; D023041:Xenograft Model Antitumor Assays; D051176:beta Catenin / Q000235:genetics / Q000378:metabolism
chemical_list: C495267:CTNNB1 protein, mouse; C503635:HNRNPC protein, human; D034482:Heterogeneous-Nuclear Ribonucleoprotein Group C; D035683:MicroRNAs; C534190:Mirn146 microRNA, mouse; D051176:beta Catenin; D014568:Urokinase-Type Plasminogen Activator; D020781:Matrix Metalloproteinase 1